Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL JOURNAL SELECTION NETWORK HELP ABOUT

Journal Selection Criteria and Standards

WPRIM Journal Selection Criteria (August 2026)

NJSC Philippines Selection Criteria (for Philippine-based journals only)

Minimum standards for the suspension and removal of WPRIM approved journals

Application and Indexing Process

Application and Submission Process for WPRIM Indexing

Journal Content Management

Candidate Journal Selection and Data Creation and Management System

The Korean Journal of Hepatology

1995  to  Present  ISSN: 1738-222X

Articles

About

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

864

results

page

of 87

1

Cite

Cite

Copy

Share

Share

Copy

Ultrastructure of chronic liver diseases: From light to electron microscopy.

Kyu Won CHUNG

The Korean Journal of Hepatology.2002;8(1):112-123.

No abstract available.
Chronic Disease ; Human ; Liver/pathology/*ultrasonography ; Liver Diseases/*pathology

Chronic Disease ; Human ; Liver/pathology/*ultrasonography ; Liver Diseases/*pathology

2

Cite

Cite

Copy

Share

Share

Copy

Peripheral Cholangiocarcinoma.

Joon Koo HAN

The Korean Journal of Hepatology.2002;8(1):110-111.

No abstract available.
Aged ; *Bile Duct Neoplasms/radiography ; Bile Ducts, Intrahepatic ; *Cholangiocarcinoma/radiography ; Female ; Human ; *Liver Neoplasms/radiography

Aged ; *Bile Duct Neoplasms/radiography ; Bile Ducts, Intrahepatic ; *Cholangiocarcinoma/radiography ; Female ; Human ; *Liver Neoplasms/radiography

3

Cite

Cite

Copy

Share

Share

Copy

Hepatocellular Carcinoma Arising in Hepatocellular Adenoma.

Mi Sun CHOE ; Eunsil YU

The Korean Journal of Hepatology.2002;8(1):107-109.

No abstract available.
Adenoma, Liver Cell/*pathology ; Aged ; Carcinoma, Hepatocellular/*pathology ; Human ; Liver Neoplasms/*pathology ; Male ; Neoplasms, Multiple Primary/*pathology

Adenoma, Liver Cell/*pathology ; Aged ; Carcinoma, Hepatocellular/*pathology ; Human ; Liver Neoplasms/*pathology ; Male ; Neoplasms, Multiple Primary/*pathology

4

Cite

Cite

Copy

Share

Share

Copy

Internet for Patient Education of Liver Diseases.

Jong Hyeok KIM ; Choong Kee PARK

The Korean Journal of Hepatology.2002;8(1):105-106.

No abstract available.
Human ; *Internet ; *Liver Diseases ; *Patient Education

Human ; *Internet ; *Liver Diseases ; *Patient Education

5

Cite

Cite

Copy

Share

Share

Copy

A Case of Fulminant Hepatic Failure in Wilson's Disease Combined with Systemic Lupus Erythematosus.

Tae Yeob KIM ; Soong Hwan LEE ; Tae Jong KIM ; Kyung Ran CHO ; Seung Chul CHO ; Sung Hee HAN ; Sun Young YANG ; Yong Woo CHUNG ; Joo Hyun SOHN ; Sang Hyun BAIK ; Sang Cheol BAE ; Dong Hoo LEE ; Choon Suhk KEE

The Korean Journal of Hepatology.2002;8(1):100-104.

Patients with systemic lupus erythematosus (SLE) have a chance of developing liver involvement in their lifetime. The main cause of liver involvement in SLE patients is previous treatment with hepatotoxic drugs or hepatotropic viral hepatitis. Wilson's disease is a hereditary disorder and is usually diagnosed in patients presenting either neuropsychiatric disorders or manifestations related to chronic liver disease. Fulminant hepatic failure as the initial manifestation of Wilson's disease is rare. The relationship between systemic lupus erythematosus and Wilson's disease has not been established. We report a case of a 12-year-old girl with SLE who presented fulminant hepatic failure as an initial manifestation of Wilson's disease. The diagnosis was established with decreased serum ceruloplasmin level and the presence of Kayser-Fleischer ring. We treated with repeated plasma exchange. Despite repeated plasma exchange she died of multi-organ failure on the 16th hospital day. Considering this case, Wilson's disease should be considered as a cause of fulminant hepatic failure, especially in juvenile age cases.
Child ; English Abstract ; Female ; Hepatolenticular Degeneration/*complications ; Human ; Liver Failure/*etiology ; Lupus Erythematosus, Systemic/*complications

Child ; English Abstract ; Female ; Hepatolenticular Degeneration/*complications ; Human ; Liver Failure/*etiology ; Lupus Erythematosus, Systemic/*complications

6

Cite

Cite

Copy

Share

Share

Copy

The Expression of E-cadherin in Human and Rat Hepatic Stellate Cells: Evidence of Epithelial-Mesenchymal Transition.

Young Suk LIM ; Hyo Suk LEE

The Korean Journal of Hepatology.2002;8(1):90-99.

BACKGROUND/AIMS: The embryonal origin of hepatic stellate cells (HSCs), the principal cells in hepatic fibrogenesis, is still intriguing. We have previously demonstrated that human HSCs express cytokeratins which suggests the epithelial origin of these cells. To further explore the origin and the differentiation of HSCs we studied the expression of E-cadherin, the specific marker of epithelial cells, in human and rat HSCs. METHODS: We studied the changing pattern of E-cadherin expression during spontaneous activation of primarily isolated human HSCs by immunofluorescence staining and RT-PCR. To confirm the expression of E-cadherin in HSCs in vivo we performed double immunofluorescence staining for E-cadherin and glial fibrillary acidic protein, the specific identification marker of quiescent rat HSCs, in normal rat liver. RESULTS: Quiescent human HSCs were labeled strongly by anti-E-cadherin monoclonal antibody at the first and seventh days after primary culture. Human HSCs, however, did not stain for E-cadherin after the first passage of culture. RT-PCR also confirmed these modulations of E-cadherin expression. Double immunofluorescence staining, performed on rat liver tissue and observed by confocal laser scanning microscopy, unequivocally revealed the membranous expression of E-cadherin in quiescent HSCs labeled by glial fibrillary acidic protein. CONCLUSIONS: Quiescent HSCs of humans and rats express E-cadherin both in vitro and in vivo. The extent of E-cadherin expression rapidly decreases during the process of spontaneous activation. Our results suggest that HSCs may be of epithelial origin and undergo epithelial-mesenchymal transition during activation process.
Animals ; Cadherins/*metabolism ; Cell Differentiation ; Cells, Cultured ; English Abstract ; Epithelial Cells/cytology ; Fluorescent Antibody Technique ; Glial Fibrillary Acidic Protein/metabolism ; Human ; Liver/cytology/*metabolism ; Mesoderm/cytology ; Rats ; Reverse Transcriptase Polymerase Chain Reaction

Animals ; Cadherins/*metabolism ; Cell Differentiation ; Cells, Cultured ; English Abstract ; Epithelial Cells/cytology ; Fluorescent Antibody Technique ; Glial Fibrillary Acidic Protein/metabolism ; Human ; Liver/cytology/*metabolism ; Mesoderm/cytology ; Rats ; Reverse Transcriptase Polymerase Chain Reaction

7

Cite

Cite

Copy

Share

Share

Copy

Interactions of Unconjugated Bilirubin with Bile Acid by Rapid Solvent Partition.

Joon Soo HAHM ; Gwang Ho MUN ; Hang Lak LEE ; Chang Soo EUN ; Joon Yong PARK ; Dong Soo HAN ; Ho Soon CHOI ; You Hern AHN

The Korean Journal of Hepatology.2002;8(1):80-89.

BACKGROUND/AIMS: Our previous studies of ionization and solubility of unconjugated bilirubin (UCB) yielded inappropriately large differences between the two carboxylic pK'a values of UCB. These data, however, were not ideal due to crystal effects, matastability, impurities of the bilirubin, and imprecision of analyses at low UCB. METHODS: The sodium salt of taurocholate (TC) was purified and dissolved in water to 100 mM. Chloroform (CHCl3) was purified by vacuum distillation. Buffers used were: citrate from pH 4 to 6, phosphate from pH 6 to 8, and borate above pH 8. All had an ionic strength of 0.10. The problems were minimized by rapid solvent partition of UCB from CHCl3 into buffered aqueous NaCl, and a new, accurate assay of low UCB in the aqueous phase which was achieved by concentrating the UCB through back extraction into small volumes of CHCl3. RESULTS: In contrast with the crystal dissolution studies, the two pK'a value were similar. H2B0, not HB-, was the dominant UCB species in the pH range of bile (6.0 to 8.0). The aqueous solubilities of UCB were 90 to 98% less. Less than 0.01% of the bile salt partitioned into the CHCl3 phase and self-association of B= was negligible. UCB solubilities in 50 mM TC were 2 to 10% of those obtained by crystal dissolution, and, up to pH 7.9, were below the maximum UCB concentration in normal human bile. CONCLUSIONS: We suggest that the markedly increased binding of UCB with each ionization step is due to the disruption of the internal hydrogen bonds of the ionized carboxyl groups on interaction with the bile salt. We propose to extend the study of partition to determine the activity and the degradation products of calcium salts of unbound bilirubin fractions.
Bilirubin/*chemistry ; Chloroform ; English Abstract ; Hydrogen-Ion Concentration ; In Vitro ; Solubility ; Solvents ; Taurocholic Acid/*chemistry

Bilirubin/*chemistry ; Chloroform ; English Abstract ; Hydrogen-Ion Concentration ; In Vitro ; Solubility ; Solvents ; Taurocholic Acid/*chemistry

8

Cite

Cite

Copy

Share

Share

Copy

Concurrent Chemo-Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis.

Jin Suk KIM ; Kwang Hyub HAN ; Do Yun LEE ; Jin Sil SEONG ; Young Hoon YOUN ; Jae Youn CHEONG ; Sang Hoon AHN ; Chae Yoon CHON ; Young Myoung MOON

The Korean Journal of Hepatology.2002;8(1):71-79.

BACKGROUND/AIMS: Advanced hepatocellular carcinoma with portal vein thrombosis has a poor prognosis. This study was undertaken to evaluate the therapeutic effects of concurrent chemo-radiation therapy in advanced hepatocellular carcinoma with portal vein thrombosis. METHODS: A total of 54 patients with advanced hepatocellular carcinoma (TNM stage IVa) were enrolled. Nineteen patients were treated with external beam radiotherapy (4,500 cGy/ 5 weeks) and intrahepatic arterial 5-FU infusion (500 mg on 1-5 day and 30-35 day, respectively) via implanted chemoport. The others were treated with intrahepatic arterial cisplatin infusion (80 mg/m2). RESULTS: In patients treated with concurrent chemo-radiation therapy, response rates at 2nd and 6th months were 42.1% and 26.3%, respectively. In patients treated with intrahepatic arterial cisplatin therapy, response rates at 2nd and 6th months were 2.9% and 0%, respectively. The median survival time was 11.6 months in concurrent chemo-radiation therapy and 4.8 months in intrahepatic arterial cisplatin infusion therapy. Concurrent chemo-radiation therapy produced better response rates and longer survival time than those of intrahepatic arterial cisplatin infusion therapy (p<0.05). CONCLUSIONS: Concurrent chemo-radiation therapy achieved favorable results in advanced hepatocellular carcinoma with portal vein thrombosis and can be considered as a treatment option for the management of advanced hepatocellular carcinoma.
Antineoplastic Agents/*administration & dosage ; Carcinoma, Hepatocellular/complications/radiotherapy/*therapy ; Cisplatin/administration & dosage ; Combined Modality Therapy ; English Abstract ; Female ; Fluorouracil/administration & dosage ; Human ; Infusions, Intra-Arterial ; Liver Neoplasms/complications/radiotherapy/*therapy ; Male ; Middle Aged ; *Portal Vein ; Prognosis ; Venous Thrombosis/*complications

Antineoplastic Agents/*administration & dosage ; Carcinoma, Hepatocellular/complications/radiotherapy/*therapy ; Cisplatin/administration & dosage ; Combined Modality Therapy ; English Abstract ; Female ; Fluorouracil/administration & dosage ; Human ; Infusions, Intra-Arterial ; Liver Neoplasms/complications/radiotherapy/*therapy ; Male ; Middle Aged ; *Portal Vein ; Prognosis ; Venous Thrombosis/*complications

9

Cite

Cite

Copy

Share

Share

Copy

Clinical and Microbiological Characteristics of Spontaneous Bacterial Peritonitis (SBP) in A Recent Five Year Period.

Hee Gon SONG ; Han Chu LEE ; Yeon Ho JOO ; Saera JUNG ; Young Hwan PARK ; Soo Hyung RYU ; Jung Woo SHIN ; Yun Jung LEE ; Young Hwa CHUNG ; Yung Sang LEE ; Dong Jin SUH

The Korean Journal of Hepatology.2002;8(1):61-70.

BACKGROUNDS/AIMS: Recently, treatment failure with the third generation of cephalosporin was increasingly noted in patients with spontaneous bacterial peritonitis (SBP). We therefore were to evaluate the pattern of antibiotic resistance and its clinical significance. METHODS: We retrospectively analyzed 580 episodes of SBP occurring between 1995 and 1999. There were 87 episodes of SBP in 1995, 222 in 1998, and 271 in 1999. The pattern of isolated organisms and antibiotic resistance, and prognostic factors for survival, were analyzed. RESULTS: Microorganisms were isolated in 41% of total episodes. The three most frequently isolated organisms were E. coli (48%), K. pneumoniae (15%), and Aeromonas (8%). The percentage of resistant strains to cefotaxime (9%, 14%, 32%) and ciprofloxacin (13%, 21%, 32%) significantly increased. The proportion of E. coli producing extended spectrum beta-lactamase (ESBL) also increased significantly (0%, 16%, 33%). The need of secondary antibiotics such as imipenem due to treatment failure was significantly increased from 0% in 1995 to 33% in 1999. Overall in-hospital mortality, however, was not changed (20%, 20%, 24%, respectively). The factor affecting early mortality was renal failure at diagnosis. Prognostic factors for long-term survival were the presence of associated malignancy and ESBL-producing microorganisms. CONCLUSION: Microorgansims resistant to third generation cephalosporin and quinolone were increasingly isolated over the 5 years in patients with SBP. Measures to prevent in-hospital spread of resistant strains and indiscreet use of antibiotics should therefore be instituted.
4-Quinolones ; Adult ; Aged ; Anti-Infective Agents/pharmacology ; Bacterial Infections/complications/*drug therapy/*microbiology/mortality ; Cephalosporin Resistance ; Drug Resistance ; English Abstract ; Female ; Human ; Liver Cirrhosis/complications ; Male ; Middle Aged ; Peritonitis/complications/*drug therapy/microbiology/mortality ; Prognosis ; Retrospective Studies ; Survival Rate

4-Quinolones ; Adult ; Aged ; Anti-Infective Agents/pharmacology ; Bacterial Infections/complications/*drug therapy/*microbiology/mortality ; Cephalosporin Resistance ; Drug Resistance ; English Abstract ; Female ; Human ; Liver Cirrhosis/complications ; Male ; Middle Aged ; Peritonitis/complications/*drug therapy/microbiology/mortality ; Prognosis ; Retrospective Studies ; Survival Rate

10

Cite

Cite

Copy

Share

Share

Copy

Efficacy and Safety of Large Volume Paracentesis in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: A Randomized Prospective Study.

Chang Hwan CHOI ; Kwang Hyub HAN ; Do Young KIM ; Jae Hee CHO ; Jae Youn CHEONG ; Kun Hoon SONG ; Chae Yoon CHON ; Young Myoung MOON

The Korean Journal of Hepatology.2002;8(1):52-60.

BACKGROUND/AIMS: Large volume paracentesis (LVP) associated with plasma volume expansion is known to be an effective and safe therapy for tense or refractory ascites in cirrhosis. Spontaneous bacterial peritonitis (SBP) is one of the frequent infections in patients with cirrhosis. We conducted a study to assess the efficacy and safety of large volume paracentesis in cirrhotic patients with SBP. METHODS: We randomly assigned 40 patients with cirrhosis and SBP to either treatment with LVP (21 patients) or general management (19 patients). LVP was defined as drainage of ascitic fluid of more than 4 liters in a single tap or loss of shifting dullness after paracentesis. LVP was performed within 48 hours after the diagnosis of SBP in the LVP group. Cefotaxime was given daily in doses that varied according to the serum creatinine level in both groups. Albumin was given at a dose of 6-8 g per 1 liter of removed ascites in the LVP group. RESULTS: After seven days of treatments, the blood chemistry test, and WBC (PMN) counts and protein concentration in the ascitic fluid were not different between the two groups. Among them, the WBC (PMN) counts were decreased significantly in both groups and protein concentrations tended to increase. Durations of abdominal tenderness and pain were shorter in the LVP group but the differences were statistically not significant. Admission periods, resolution rates of SBP after seven days of treatment, complication rates and in-hospital mortality rates were not different between the two groups. CONCLUSIONS:: The two treatment methods demonstrated almost the same effectiveness and safety. The symptoms were improved slightly faster in the LVP group. We concluded that large volume paracentesis is not an absolute contraindication and can be a tolerable and safe therapy in some selected cirrhotic patients with tense ascites and SBP.
Adult ; Aged ; Ascites/etiology/*therapy ; Bacterial Infections/*complications ; English Abstract ; Female ; Human ; Liver Cirrhosis/complications/*therapy ; Male ; Middle Aged ; *Paracentesis/methods ; Peritonitis/complications/microbiology/*therapy ; Plasma Substitutes/administration & dosage ; Prospective Studies

Adult ; Aged ; Ascites/etiology/*therapy ; Bacterial Infections/*complications ; English Abstract ; Female ; Human ; Liver Cirrhosis/complications/*therapy ; Male ; Middle Aged ; *Paracentesis/methods ; Peritonitis/complications/microbiology/*therapy ; Plasma Substitutes/administration & dosage ; Prospective Studies

Country

Republic of Korea

Publisher

Korean Association for the Study of the Liver

ElectronicLinks

http://koreamed.org/JournalVolume.php?id=2005

Editor-in-chief

Jin Wook Kim

E-mail

kasl@kams.or.kr

Abbreviation

Korean J Hepatol

Vernacular Journal Title

대한간학회지

ISSN

1738-222X

EISSN

2093-8047

Year Approved

2007

Current Indexing Status

Currently Indexed

Start Year

1995

Description

Clinical and Molecular Hepatology(CMH), an official journal of The Korean Association for the Study of the Liver, is issued quarterly and published in English. The aim of the journal is to provide a forum for medical doctors and basic scientists working in the field of hepatology.

Current Title

Clinical and Molecular Hepatology

Previous Title

The Korean Journal of Hepatology

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.